Literature DB >> 11929803

A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.

Murat O Arcasoy1, Aysen F Karayal, Harvey M Segal, Joseph G Sinning, Bernard G Forget.   

Abstract

Primary familial erythrocytosis (familial polycythemia) is a rare myeloproliferative disorder with an autosomal dominant mode of inheritance. We studied a new kindred with autosomal dominantly inherited familial erythrocytosis. The molecular basis for the observed phenotype of isolated erythrocytosis is heterozygosity for a novel nonsense mutation affecting codon 399 in exon 8 of the erythropoietin receptor (EPOR) gene, encoding an EpoR peptide that is truncated by 110 amino acids at its C-terminus. The new EPOR gene mutation 5881G>T was found to segregate with isolated erythrocytosis in the affected family and this mutation represents the most extensive EpoR truncation reported to date, associated with familial erythrocytosis. Erythroid progenitors from an affected individual displayed Epo hypersensitivity in in vitro methylcellulose cultures, as indicated by more numerous erythroid burst-forming unit-derived colonies in low Epo concentrations compared to normal controls. Expression of mutant EpoR in interleukin 3-dependent hematopoietic cells was associated with Epo hyperresponsiveness compared to cells expressing wild-type EpoR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929803     DOI: 10.1182/blood.v99.8.3066

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activity.

Authors:  Que T Lambert; Anuradha Pradhan; J Devon Roll; Gary W Reuther
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

2.  A case of primary familial congenital polycythemia with a novel EPOR mutation: possible spontaneous remission/alleviation by menstrual bleeding.

Authors:  Naohisa Toriumi; Makoto Kaneda; Naoki Hatakeyama; Hiromi Manabe; Kazuki Okajima; Yukari Sakurai; Masayo Yamamoto; Takeo Sarashina; Katsuya Ikuta; Hiroshi Azuma
Journal:  Int J Hematol       Date:  2018-04-05       Impact factor: 2.490

3.  Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Authors:  Ilaria V Libani; Ella C Guy; Luca Melchiori; Raffaella Schiro; Pedro Ramos; Laura Breda; Thomas Scholzen; Amy Chadburn; YiFang Liu; Margrit Kernbach; Bettina Baron-Lühr; Matteo Porotto; Maria de Sousa; Eliezer A Rachmilewitz; John D Hood; M Domenica Cappellini; Patricia J Giardina; Robert W Grady; Johannes Gerdes; Stefano Rivella
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

Review 4.  Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.

Authors:  Kenneth Kaushansky
Journal:  Cytokine Growth Factor Rev       Date:  2006-10-20       Impact factor: 7.638

5.  Primary shunt hyperbilirubinaemia in a large four-generation family confirming autosomal dominant genetic disorder.

Authors:  Chun-Lian Wang; Xiao-Wei Liu; Fang-Gen Lu; Xiao-Ping Wu; Chun-Hui Ouyang; Dong-Ye Yang
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

6.  A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia.

Authors:  Kacey O'Rourke; David J Fairbairn; Kathryn A Jackson; Kirk L Morris; Siok-Keen Tey; Glen A Kennedy
Journal:  Int J Hematol       Date:  2011-03-25       Impact factor: 2.490

Review 7.  The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.

Authors:  Stephanie S Watowich
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

Review 8.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

9.  Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.

Authors:  Andrea Inthal; Gerd Krapf; Dominik Beck; Ruth Joas; Max O Kauer; Lukas Orel; Gerhard Fuka; Georg Mann; E Renate Panzer-Grümayer
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

10.  EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts.

Authors:  Jing Fang; Madhu Menon; William Kapelle; Olga Bogacheva; Oleg Bogachev; Estelle Houde; Sarah Browne; Pradeep Sathyanarayana; Don M Wojchowski
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.